U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

Showing 1 - 10 of 23 results

structurally diverse
Status:
Investigational
Source:
INN:rilimogene galvacirepvec [INN]
Source URL:

Class:
STRUCTURALLY DIVERSE

structurally diverse
Status:
Investigational
Source:
INN:rilimogene glafolivec [INN]
Source URL:

Class:
STRUCTURALLY DIVERSE

structurally diverse
Status:
Investigational
Source:
INN:raxorulimogene belzovacirepvec [INN]
Source URL:

Class:
STRUCTURALLY DIVERSE

structurally diverse
Status:
Investigational
Source:
INN:mesmulogene ancovacivec [INN]
Source URL:

Class:
STRUCTURALLY DIVERSE

structurally diverse
Status:
Investigational
Source:
INN:tipapkinogene sovacivec [INN]
Source URL:

Class:
STRUCTURALLY DIVERSE

structurally diverse
Status:
Investigational
Source:
INN:pexastimogene devacirepvec [INN]
Source URL:

Class:
STRUCTURALLY DIVERSE

structurally diverse
Status:
Investigational
Source:
INN:olvimulogene nanivacirepvec [INN]
Source URL:

Class:
STRUCTURALLY DIVERSE

structurally diverse
Status:
Investigational
Source:
NCT03493945: Phase 1/Phase 2 Interventional Recruiting Metastatic Prostate Cancer
(2018)
Source URL:

Class:
STRUCTURALLY DIVERSE

structurally diverse
Status:
Investigational
Source:
NCT00397345: Phase 3 Interventional Completed Clear Cell Renal Carcinoma
(2006)
Source URL:

Class:
STRUCTURALLY DIVERSE

structurally diverse
Status:
Investigational
Source:
NCT01602562: Phase 3 Interventional Completed Herpes Simplex
(2012)
Source URL:

Class:
STRUCTURALLY DIVERSE